Related Experiment Video
Updated: Apr 18, 2026

10:46
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
11.9K
Dextromethorphan for Restless Legs Syndrome: Testing the Glutamate Theory
Melissa Khalil1, Estefany Garces Delgado2, Brynn Dredla2
1Sleep Medicine, James H. Quillen VA Medical Center, Johnson City, USA.
Cureus
|April 17, 2026
Summary
Dextromethorphan (DXM) offers potential relief for severe restless legs syndrome (RLS) when standard treatments fail. This case study highlights significant symptom improvement in a patient refractory to other therapies.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Restless Legs Syndrome (RLS) is a common neurological disorder characterized by an urge to move the legs, often leading to sleep disruption.
- Current understanding implicates dopaminergic dysfunction and iron deficiency, with emerging evidence suggesting roles for adenosinergic and glutamatergic systems.
- Treatment-refractory RLS poses a significant clinical challenge, necessitating exploration of novel therapeutic avenues.
Keywords:
adenosine pathwaysdextromethorphandrug repurposingglutamatergic signalingnmda receptor antagonistrestless legs syndromesleep disordersMore Related Videos
Related Concept Videos
Restless Leg Syndrome and Night Terrors
854
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
854
Myasthenia Gravis: Diagnostic Tests
3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Drugs Acting on Autonomic Ganglia: Stimulants
2.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
940
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
940

